Substance

ID:182855

Cefotaxime sodium salt

Names and Identifiers
Synonyms
Cefotaxim sodium salt 钠盐Cefotaxime sodium saltCefotaxime sodium salt 钠盐
IUPAC Traditional name
sodium cefotaxime(1-)
IUPAC name
sodium (6R,7R)-3-[(acetyloxy)methyl]-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Registration numbers
Beilstein Number
CAS Number
EC Number
MDL Number
PubChem SID
Properties
Safety Information
GHS Precautionary statements
P261-P280-P342+P311
Risk Statements
42/43
GHS Pictograms
GHS08
Respiratory sensitization, category 1
Germ cell mutagenicity, categories 1A,1B,2
Carcinogenicity, categories 1A,1B,2
Reproductive toxicity, categories 1A,1B,2
Specific Target Organ Toxicity – Single exposure, categories 1,2
Specific Target Organ Toxicity – Repeated exposure, categories 1,2
Aspiration Hazard, category 1
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
GHS Signal Word
Danger
German water hazard class
2
GHS Hazard statements
H317-H334
Storage Temperature
2-8°C
European Hazard Symbols
Harmful Harmful (Xn)
RTECS
XI0250000
Safety Statements
22-36/37
Product Information
Potency
916-964 μg per mg
Suitability
suitable for 1694 per US EPA
Molecule Details
Biochem/physiol Actions
Used to study the effect of expression, binding and inhibition of penicillin-binding proteins especially PBP2 on bacterial cell wall mucopeptide synthesis.
Cefotaxim inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs) which inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls. As a result, bacteria lyse due to cell wall autolytic enzymes.
Other Notes
Broad spectrum third generation cephalosporin antibiotic.
Application
Cefotaxim is a broad spectrum third generation cephalosporin antibiotic that is used to study the effect of expression, binding and inhibition of penicillin-binding proteins especially PBP2 on bacterial cell wall mucopeptide synthesis. It has been used to find new residues involved in cefotaxime hydrolysis in CTX-M β-lactamases1, to study antibiotic-susceptible and -resistant Streptococcus pneumoniae infections 2, and to study pneumococcal pneumonia and the pharmokinetics of various treatments3.
Protocols & Applications
Antibiotic Selector for application, solubility, solution stability, working concentration, and mode of action information
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data